PMVP

Pmv Pharmaceuticals Inc

PMVP.US pmvpharma.com + Research + Basket
CIK 0001699382
Employees 54
Phone 609 642 6670
Fiscal year end December
IPO Sep 25, 2020
Address 400 Alexander Park Drive, Princeton, NJ, United States, 08540
1.28
-0.05 (-3.77%)
USD · NASDAQ
52-week range
1.02
1.91
Trading at 29% of the 52-week range
Market Cap
96.28M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
1.34
Div. Yield
N/A
% Institutions
46.35%
% Insiders
2.37%

1 Year

-2.7%

3 Year

-37.2%

10 Year

-96.6%
Description

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.

Actions

Add an action for PMVP.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. David H. Mack Ph.D. Co-Founder, CEO, President & Director 1962
Dr. Arnold J. Levine Ph.D. Co-Founder, Independent Director & Member of Scientific Advisory Board 1940
Mr. Robert Ticktin J.D. General Counsel, COO & Company Secretary 1962
Dr. Deepika Jalota Pharm.D. Chief Development Officer 1977
Mr. Michael Carulli CFO & Principal Financial & Accounting Officer 1974
Mr. Tim Smith M.B.A. Senior VP and Head of Corporate Development & Investor Relations NA
Mr. Steve Dyott Vice President of Marketing NA
Ms. Crystal Zuckerman Vice President of Human Resources NA
Dr. Binh Vu Ph.D. Senior Vice President of Drug Discovery & CMC NA
Dr. Marc Fellous M.D. Senior VP and Head of Clinical Development & Medical Affairs NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Oct 23, 2025 Orbimed Advisors Llc N/A Sale 1.00M $1.52 $1.52M SEC
Sep 10, 2025 Orbimed Advisors Llc N/A Sale 500.00K $1.80 $900.00K SEC
Jul 01, 2025 David Henry Mack N/A Sale 58.41K $1.06 $61.92K SEC
Jul 01, 2025 Deepika Jalota N/A Sale 33.07K $1.06 $35.05K SEC
Jul 01, 2025 Robert Ticktin N/A Sale 23.15K $1.06 $24.54K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BML Capital Management LLC 5.33M Jun 30, 2026 7.06% $4.06 0.19%
TANG CAPITAL MANAGEMENT LLC 4.25M Jun 30, 2026 5.62% $0.26 0.00%
Sio Capital Management, LLC 2.63M Jun 30, 2026 3.49% $0.58 -14.38%
Euclidean Capital LLC 2.63M Jun 30, 2026 3.48% $0.80 0.00%
Adage Capital Partners Gp LLC 2.36M Jun 30, 2026 3.13% $0.00 26.88%
Acadian Asset Management LLC 2.22M Jun 30, 2026 2.93% $0.00 0.00%
Vanguard Capital Management, LLC 2.01M Jun 30, 2026 2.66% $0.00 1.88%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 1.96M Jun 30, 2026 2.60% $0.11 -31.79%
Two Sigma Investments LLC 1.95M Jun 30, 2026 2.59% $0.00 3.69%
Eversept Partners, LP 1.89M Jun 30, 2026 2.50% $0.13 -19.48%
BlackRock Inc 919.82K Jun 30, 2026 1.22% $0.00 5.20%
Assenagon Asset Management SA 660.01K Jun 30, 2026 0.87% $0.00 82.94%
Stonepine Capital Management Llc 536.09K Jun 30, 2026 0.71% $0.41 -24.29%
Geode Capital Management, LLC 473.16K Jun 30, 2026 0.63% $0.00 -4.59%
Aldebaran Capital LLC 467.43K Jun 30, 2026 0.62% $0.47 -1.25%
Bridgeway Capital Management, LLC 428.85K Jun 30, 2026 0.57% $0.01 0.00%
Verdad Advisers, LP 362.36K Jun 30, 2026 0.48% $0.47 101.13%
Walleye Trading Advisors, LLC 335.69K Jun 30, 2026 0.44% $0.00 0.00%
Marshall Wace Asset Management Ltd 321.61K Jun 30, 2026 0.43% $0.00 -25.91%
Vanguard Fiduciary Trust Co 254.78K Jun 30, 2026 0.34% $0.00 -14.54%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 2.38M 3.16% ▲ 60.35% Sep 30, 2026
2 Meridian Small Cap Growth Legacy 1.06M 1.40% ▼ 2.06% Jun 30, 2026
3 Bridgeway Ultra-Small Company 331.45K 0.44% ▲ 0.00% Jun 30, 2026
4 Fidelity Extended Market Index 214.38K 0.28% ▼ 0.53% Aug 31, 2026
5 iShares Micro-Cap ETF 145.74K 0.19% ▲ 0.00% Oct 29, 2026
6 EA Bridgeway Ultra-Small Company Mkt ETF 74.76K 0.10% ▼ 0.36% Oct 29, 2026
7 Goldman Sachs Absolute Ret Trckr Instl 74.05K 0.10% ▼ 4.62% Jun 30, 2026
8 Fidelity Total Market Index 71.19K 0.09% ▲ 0.00% Aug 31, 2026
9 Nationwide Bailard Sm Cp Val M 61.50K 0.08% ▲ 0.00% Jan 31, 2026
10 Fidelity Series Total Market Index 59.92K 0.08% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $96.28M
EBITDA: $-79.54M
Book Value: $1.34
Earnings/Share: $-1.42
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -42.39%
ROE (TTM): -70.93%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $-5.44M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 75.51M
Shares Float: 43.29M
% Insiders: 2.37%
% Institutions: 46.35%
Shares Short: 2.29M
Shares Short (Prior Month): 2.79M
Short Ratio: 2.59
Short % Float: 3.10%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-133.00K
Gross Profit
subtotal
$-133.00K
SG&A
adjust
$-16.33M
R&D
adjust
$-69.88M
Operating Income
subtotal
$-86.21M
Other / Non-Operating Items
adjust
$8.46M
Net Income
subtotal
$-77.74M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PMVP.US!